Exploratory observational study reports weight loss and metabolic improvements in obese individuals using Semaglutide, suggesting its value in treatment.
Key Points
To evaluate the impact of weekly Semaglutide on weight, body composition, and metabolic health in individuals with obesity.
Exploratory observational study of 37 patients with obesity
Measurements of anthropometry, body composition, and fasting biochemistry at baseline and 3 months
Used parametric and non-parametric tests for analysis.
Body weight decreased by a median of 8.0 kg (p < 0.001) at 3 months